SelgasR., del PesoG., BajoM.A., CastroM.A., MolinaS., CirugedaA.Spontaneous VEGF production by cultured peritoneal mesothelial cells from patients on peritoneal dialysis.Perit Dial Int2000; 20: 798–801.
2.
InagiR., MiyataT., YamamotoT., SuzukiD., UrakamiK., SaitoA.Glucose degradation product methylglyoxal enhances the production of VEGF in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis.FEBS Lett1999; 463: 260–4.
3.
McLarenJ., PrenticeA., Charnock–JonesD.S., MillicanS.A., MullerK.H., SharkeyA.M.Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.J Clin Invest1996; 98: 482–9.
4.
HarmeyJ.H., DimitriadisE., KayE., RedmondH.P., Bouchier–HayesD.Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.Ann Surg Oncol1998; 5: 271–8.
5.
ZweersM.M., de WaartD.R., SmitW., StruijkD.G., KredietR.T.Growth factors VEGF and TGF-beta1 in peritoneal dialysis.J Lab Clin Med1999; 134: 124–32.
6.
VasS.I.Peritonitis during CAPD. A mixed bag.Perit Dial Bull1981; 1: 47–9.
CombetS., MiyataT., MoulinP., PouthierD., GoffinE., DevuystO.Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis.J Am Soc Nephrol2000; 11: 717–28.
9.
ZweersM.M., StruijkD.G., SmitW., KredietR.T.Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.J Lab Clin Med2001; 137: 125–32.
10.
FerraraN.Role of vascular endothelial growth factor in the regulation of angiogenesis.Kidney Int1999; 56: 794–814.
ProescholdtM.A., HeissJ.D., WalbridgeS., MuhlhauserJ., CapogrossiM.C., OldfieldE.H.Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain.J Neuropathol Exp Neurol1999; 58: 613–27.
13.
BrownL.F., OlbrichtS.M., BerseB., JackmanR.W., MatsuedaG., TognazziK.A.Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.J Immunol1995; 154: 2801–7.
14.
LinC.Y., ChenW.P., YangL.Y., ChenA., HuangT.P.Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.Am J Nephrol1998; 18: 513–19.
15.
OffnerF.A., FeichtingerH., StadlmannS., ObristP., MarthC., KlinglerP.Transforming growth factor-β synthesis by human peritoneal mesothelial cells: induction by interleukin-1.Am J Pathol1996; 148: 1679–88.
16.
WongT.Y., SzetoC.C., LaiK.B., LamC.W., LaiK.N., LiP.K.Longitudinal study of peritoneal membrane function in CAPD: relationship with peritonitis and fibrosing factors.Perit Dial Int2000; 20: 679–86.
17.
HaH., YuM.R., LeeH.B.High glucose-induced PKC activation mediates TGF-beta1 and fibronectin synthesis by peritoneal mesothelial cells.Kidney Int2001; 59: 463–70.
